Literature DB >> 28096541

The mucosal immune system: master regulator of bidirectional gut-brain communications.

Nick Powell1, Marjorie M Walker2, Nicholas J Talley2.   

Abstract

Communication between the brain and gut is not one-way, but a bidirectional highway whereby reciprocal signals between the two organ systems are exchanged to coordinate function. The messengers of this complex dialogue include neural, metabolic, endocrine and immune mediators responsive to diverse environmental cues, including nutrients and components of the intestinal microbiota (microbiota-gut-brain axis). We are now starting to understand how perturbation of these systems affects transition between health and disease. The pathological repercussions of disordered gut-brain dialogue are probably especially pertinent in functional gastrointestinal diseases, including IBS and functional dyspepsia. New insights into these pathways might lead to novel treatment strategies in these common gastrointestinal diseases. In this Review, we consider the role of the immune system as the gatekeeper and master regulator of brain-gut and gut-brain communications. Although adaptive immunity (T cells in particular) participates in this process, there is an emerging role for cells of the innate immune compartment (including innate lymphoid cells and cells of the mononuclear phagocyte system). We will also consider how these key immune cells interact with the specific components of the enteric and central nervous systems, and rapidly respond to environmental variables, including the microbiota, to alter gut homeostasis.

Entities:  

Mesh:

Year:  2017        PMID: 28096541     DOI: 10.1038/nrgastro.2016.191

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  216 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure.

Authors:  K S Mark; D W Miller
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

3.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.

Authors:  Evangelos Giamarellos-Bourboulis; Jie Tang; Emmannouil Pyleris; Aikaterini Pistiki; Charalambos Barbatzas; Jordan Brown; Clarence C Lee; Timothy T Harkins; Gene Kim; Stacy Weitsman; Gillian M Barlow; Vincent A Funari; Mark Pimentel
Journal:  Scand J Gastroenterol       Date:  2015-04-11       Impact factor: 2.423

5.  Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients.

Authors:  A C Ford; N J Talley; M M Walker; M P Jones
Journal:  Aliment Pharmacol Ther       Date:  2014-08-08       Impact factor: 8.171

6.  Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors.

Authors:  J R Goodhand; M Wahed; J E Mawdsley; A D Farmer; Q Aziz; D S Rampton
Journal:  Inflamm Bowel Dis       Date:  2012-02-22       Impact factor: 5.325

7.  Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

Authors:  Cesare Cremon; Luciana Gargano; Antonio M Morselli-Labate; Donatella Santini; Rosanna F Cogliandro; Roberto De Giorgio; Vincenzo Stanghellini; Roberto Corinaldesi; Giovanni Barbara
Journal:  Am J Gastroenterol       Date:  2009-01-13       Impact factor: 10.864

8.  Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat.

Authors:  S Kent; F Rodriguez; K W Kelley; R Dantzer
Journal:  Physiol Behav       Date:  1994-11

Review 9.  The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.

Authors:  Rimma Goldberg; Natalie Prescott; Graham M Lord; Thomas T MacDonald; Nick Powell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05       Impact factor: 46.802

10.  Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.

Authors:  Hazel Everitt; Sabine Landau; Paul Little; Felicity L Bishop; Paul McCrone; Gilly O'Reilly; Nicholas Coleman; Robert Logan; Trudie Chalder; Rona Moss-Morris
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

View more
  84 in total

Review 1.  Th17 cells in depression.

Authors:  Eléonore Beurel; Jeffrey A Lowell
Journal:  Brain Behav Immun       Date:  2017-08-03       Impact factor: 7.217

Review 2.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

3.  Intestinal CD4 Depletion in HIV / SIV Infection.

Authors:  Ronald S Veazey
Journal:  Curr Immunol Rev       Date:  2019

4.  Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the AppNL-G-F Mouse Model of Alzheimer's Disease.

Authors:  Mona Sohrabi; Heidi L Pecoraro; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 5.  New "programmers" in tissue macrophage activation.

Authors:  Anna C Aschenbrenner; Joachim L Schultze
Journal:  Pflugers Arch       Date:  2017-02-09       Impact factor: 3.657

6.  Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder.

Authors:  Zhou Dan; Xuhua Mao; Qisha Liu; Mengchen Guo; Yaoyao Zhuang; Zhi Liu; Kun Chen; Junyu Chen; Rui Xu; Junming Tang; Lianhong Qin; Bing Gu; Kangjian Liu; Chuan Su; Faming Zhang; Yankai Xia; Zhibin Hu; Xingyin Liu
Journal:  Gut Microbes       Date:  2020-04-21

Review 7.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.

Authors:  Daniel M Chopyk; Arash Grakoui
Journal:  Gastroenterology       Date:  2020-06-20       Impact factor: 22.682

Review 8.  The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.

Authors:  Andrea Shin; Geoffrey A Preidis; Robert Shulman; Purna C Kashyap
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-25       Impact factor: 11.382

Review 9.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

10.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.